- Revolution of Novel Direct Peroral Cholangioscopy: Another Step Beyond Limitations
-
Chantarojanasiri T
- KMID: 2531231
- Gut Liver.
- 2022 Jul;16(4):499-500.
- doi: 10.5009/gnl220274
-
- CITED
-
- Close
- SHARE
-
- Close
- Fatty Liver Disease and Cardiovascular Risk: Impact of Metabolic Dysfunctions
-
Lee JI
- KMID: 2531230
- Gut Liver.
- 2022 Jul;16(4):497-498.
- doi: 10.5009/gnl220276
-
- CITED
-
- Close
- SHARE
-
- Close
- Role of Tegoprazan in Helicobacter pylori Eradication Therapy
-
Lee J
- KMID: 2531228
- Gut Liver.
- 2022 Jul;16(4):493-494.
- doi: 10.5009/gnl220272
-
- CITED
-
- Close
- SHARE
-
- Close
- Is the Risk for Venous Thromboembolism in East Asian Patients with Inflammatory Bowel Disease Comparable to That in Western Patients?
-
Hwang SW
- KMID: 2531229
- Gut Liver.
- 2022 Jul;16(4):495-496.
- doi: 10.5009/gnl220279
-
- CITED
-
- Close
- SHARE
-
- Close
- Antiviral Prophylaxis Against Hepatitis B Virus in Patients Treated with Anti-Tumor Necrosis Factor α Agents for Inflammatory Bowel Disease
-
Kang EA, Cheon JH
- KMID: 2531232
- Gut Liver.
- 2022 Jul;16(4):501-502.
- doi: 10.5009/gnl220186
-
- CITED
-
- Close
- SHARE
-
- Close
- Gut Microbiota Alteration Influences Colorectal Cancer Metastasis to the Liver by Remodeling the Liver Immune Microenvironment
-
Yuan N, Li X, Wang M, Zhang Z, Qiao L, Gao Y, Xu X, Zhi J, Li Y, Li Z, Jia Y
- KMID: 2531240
- Gut Liver.
- 2022 Jul;16(4):575-588.
- doi: 10.5009/gnl210177
Background/Aims:This study aimed to explore the effect of gut microbiota-regulated Kupffer cells (KCs) on colorectal cancer (CRC) liver metastasis. Methods: A series of in vivo and in vitro researches were showed... -
- CITED
-
- Close
- SHARE
-
- Close
- Management of Helicobacter pylori Infection: A Comparison between Korea and the United States
-
Kim SE, Hwang JH
- KMID: 2531233
- Gut Liver.
- 2022 Jul;16(4):503-514.
- doi: 10.5009/gnl210224
Helicobacter pylori has been well known to cause gastritis, peptic ulcers, mucosa-associated lymphoid tissue, and gastric cancer. The importance of H. pylori eradication has been emphasized; however, the management of... -
- CITED
-
- Close
- SHARE
-
- Close
- Endoscopic Reintervention for Recurrence of Malignant Biliary Obstruction: Developing the Best Strategy
-
Takenaka M, Kudo M
- KMID: 2531235
- Gut Liver.
- 2022 Jul;16(4):525-534.
- doi: 10.5009/gnl210228
Drainage therapy for malignant biliary obstruction (MBO) includes trans-papillary endoscopic retrograde biliary drainage (ERBD), percutaneous transhepatic biliary drainage (PTBD), and transgastrointestinal endoscopic ultrasound-guided biliary drainage (EUS-BD). With the development of... -
- CITED
-
- Close
- SHARE
-
- Close
- Insulin-Like Growth Factor-1 Receptor Targeted Fluorescent Imaging for Gallbladder Cancer in Orthotopic Mouse Models
-
Choi JH, Park JY
- KMID: 2531243
- Gut Liver.
- 2022 Jul;16(4):606-612.
- doi: 10.5009/gnl210164
Background/Aims: Gallbladder cancer is fatal, but fluorescent imaging technology can facilitate timely diagnosis and improve patient outcomes. Fluorophore-conjugated insulin-like growth factor-1 receptor (IGF-1R) targeted antibodies were used to visualize gallbladder... -
- CITED
-
- Close
- SHARE
-
- Close
- Therapeutic Drug Monitoring of Biologics for Patients with Inflammatory Bowel Diseases: How, When, and for Whom?
-
Wu JF
- KMID: 2531234
- Gut Liver.
- 2022 Jul;16(4):515-524.
- doi: 10.5009/gnl210262
During the past decade, we have entered an era of biologics for the treatment of Crohn’s disease and ulcerative colitis. The therapeutic goal of inflammatory bowel disease (IBD) management has... -
- CITED
-
- Close
- SHARE
-
- Close
- Metabolic Dysfunction-Associated Fatty Liver Disease Better Predicts Incident Cardiovascular Disease
-
Jeong S, Oh YH, Choi S, Chang J, Kim SM, Son JS, Lee G, Kim W, Park SM
- KMID: 2531241
- Gut Liver.
- 2022 Jul;16(4):589-598.
- doi: 10.5009/gnl210256
Background/Aims: Metabolic dysfunction (MD)-associated fatty liver disease is a new positive diagnostic criterion based on hepatic steatosis and MD. However, a comprehensive evaluation on the association of MD and hepatic... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-term Outcomes of Additional Endoscopic Treatments for Patients with Positive Lateral Margins after Endoscopic Submucosal Dissection for Early Gastric Cancer
-
Kim TS, Min BH, Min YW, Lee H, Rhee PL, Kim JJ, Lee JH
- KMID: 2531237
- Gut Liver.
- 2022 Jul;16(4):547-554.
- doi: 10.5009/gnl210203
Background/Aims: It is uncertain whether additional endoscopic treatment may be chosen over surgery in patients with positive lateral margins (pLMs) as the only non-curative factor after endoscopic submucosal dissection (ESD)... -
- CITED
-
- Close
- SHARE
-
- Close
- Venous Thromboembolism Risk in Asian Patients with Inflammatory Bowel Disease: A Population-Based Nationwide Inception Cohort Study
-
Kim SY, Cho YS, Kim HS, Lee JK, Kim HM, Park HJ, Kim H, Kim J, Kang DR
- KMID: 2531238
- Gut Liver.
- 2022 Jul;16(4):555-566.
- doi: 10.5009/gnl210190
Background/Aims: Inflammatory bowel disease (IBD) is associated with the occurrence of venous thromboembolism (VTE). However, to date, there have been few studies on the risk of VTE in Asian IBD... -
- CITED
-
- Close
- SHARE
-
- Close
- Genetic, Clinicopathological, and Radiological Features of Intrahepatic Cholangiocarcinoma with Ductal Plate Malformation Pattern
-
Chung T, Rhee H, Shim HS, Yoo JE, Choi GH, Kim H, Park YN
- KMID: 2531244
- Gut Liver.
- 2022 Jul;16(4):613-624.
- doi: 10.5009/gnl210174
Background/Aims: Intrahepatic cholangiocarcinoma (iCCA) with a ductal plate malformation (DPM) pattern is a recently recognized rare variant. The genomic profile of iCCA with DPM pattern needs to be elucidated. Methods: Cases... -
- CITED
-
- Close
- SHARE
-
- Close
- Risk of Hepatitis B Virus (HBV) Reactivation in Patients with Immune-Mediated Inflammatory Diseases Receiving Biologics: Focus on the Timing of Biologics after Anti-HBV Treatment
-
Ahn SM, Choi J, Ye BD, Yang SK, Oh JS, Kim Y, Lee C, Yoo B, Park SH, Hong S
- KMID: 2531239
- Gut Liver.
- 2022 Jul;16(4):567-574.
- doi: 10.5009/gnl210204
Background/Aims: Anti-hepatitis B virus (HBV) therapy is required for patients with HBV infection receiving biologics because of the high risk of HBV reactivation. However, it is unclear when to start... -
- CITED
-
- Close
- SHARE
-
- Close
- CD40 Agonists Alter the Pancreatic Cancer Microenvironment by Shifting the Macrophage Phenotype toward M1 and Suppress Human Pancreatic Cancer in Organotypic Slice Cultures
-
Lim CY, Chang JH, Lee WS, Kim J, Park IY
- KMID: 2531247
- Gut Liver.
- 2022 Jul;16(4):645-659.
- doi: 10.5009/gnl210311
Background/Aims: CD40 agonists are thought to generate antitumor effects on pancreatic cancer via macrophages and T cells. We aimed to investigate the role of CD40 agonists in the differentiation of... -
- CITED
-
- Close
- SHARE
-
- Close
- Diagnostic Concordance and Preoperative Risk Factors for Malignancy in Pancreatic Mucinous Cystic Neoplasms
-
Kim GH, Choi K, Paik N, Lee KT, Lee JK, Lee KH, Han IW, Kang SH, Heo JS, Park JK
- KMID: 2531246
- Gut Liver.
- 2022 Jul;16(4):637-644.
- doi: 10.5009/gnl210231
Background/Aims: As pancreatic mucinous cystic neoplasms (MCNs) are considered premalignant lesions, the current guidelines recommend their surgical resection. We aimed to investigate the concordance between preoperative and postoperative diagnoses and... -
- CITED
-
- Close
- SHARE
-
- Close
- Establishment of Patient-Derived Pancreatic Cancer Organoids from Endoscopic Ultrasound-Guided Fine-Needle Aspiration Biopsies
-
Lee JH, Kim H, Lee SH, Ku JL, Chun JW, Seo HY, Kim SC, Paik WH, Ryu JK, Lee SK, Lowy AM, Kim YT
- KMID: 2531245
- Gut Liver.
- 2022 Jul;16(4):625-636.
- doi: 10.5009/gnl210166
Background/Aims: Three-dimensional cultures of human pancreatic cancer tissue also known as “organoids” have largely been developed from surgical specimens. Given that most patients present with locally advanced and/or metastatic disease,... -
- CITED
-
- Close
- SHARE
-
- Close
- Utility of Direct Peroral Cholangioscopy Using a Multibending Ultraslim Endoscope for Difficult Common Bile Duct Stones
-
Lee WM, Moon JH, Lee YN, Shin IS, Lee TH, Yang JK, Cha SW, Cho YD, Park SH
- KMID: 2531242
- Gut Liver.
- 2022 Jul;16(4):599-605.
- doi: 10.5009/gnl210355
Background/Aims: Treatment options for difficult bile duct stones are limited. Direct peroral cholangioscopy (POC)-guided lithotripsy may be an option. A newly developed multibending (MB) ultraslim endoscope has several structural features... -
- CITED
-
- Close
- SHARE
-
- Close
- Triple Therapy-Based on Tegoprazan, a New Potassium-Competitive Acid Blocker, for First-Line Treatment of Helicobacter pylori Infection: A Randomized, Double-Blind, Phase III, Clinical Trial
-
Choi YJ, Lee YC, Kim JM, Kim JI, Moon JS, Lim YJ, Baik GH, Son BK, Lee HL, Kim KO, Kim N, Ko KH, Jung HK, Shim KN, Chun HJ, Kim BW, Lee H, Kim JH, Chung H, Kim SG, Jang JY
- KMID: 2531236
- Gut Liver.
- 2022 Jul;16(4):535-546.
- doi: 10.5009/gnl220055
Background/Aims: We examined the efficacy and safety of tegoprazan as a part of first-line triple therapy for Helicobacter pylori eradication. Methods: A randomized, double-blind, controlled, multicenter study was performed to evaluate... -
- CITED
-
- Close
- SHARE
-
- Close
